Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;26(8):742-9.
doi: 10.1111/pai.12391. Epub 2015 May 11.

Asthma and allergy in children with and without prior measles, mumps, and rubella vaccination

Clara Amalie Gade Timmermann  1 , Christa Elyse Osuna  2   3 , Ulrike Steuerwald  4 , Pál Weihe  4 , Lars K Poulsen  5 , Philippe Grandjean  1   3
Affiliations

Asthma and allergy in children with and without prior measles, mumps, and rubella vaccination

Clara Amalie Gade Timmermann et al. Pediatr Allergy Immunol. 2015 Dec.

Abstract

Background: The existing literature on the association between measles vaccination and subsequent risk of allergic disease is inconclusive. The aim of this study was, therefore, to determine whether measles, mumps, and rubella (MMR) vaccination administered in early childhood was associated with asthma and allergic diseases at ages 5, 7 and 13 yrs in a birth cohort.

Methods: In the Faroe Islands, 640 children were followed from birth. Follow-up examinations at ages 5, 7 and 13 yrs included a physical examination and a maternal questionnaire about the child's health. At age 7, total and grass-specific IgE was quantified in the child's serum, and at age 13, the children underwent skin prick tests (SPT). The child's vaccination card was reviewed at examinations.

Results: At age 5, 533 of 555 children had been vaccinated for MMR. After confounder adjustment, we found early life MMR vaccination to be associated with a two-third reduction in the odds of asthma (OR: 0.33, 95% CI: 0.12; 0.90) and hypersensitivity/allergy (OR: 0.32, 95% CI: 0.11; 0.88) at age 5, and the substantially decreased odds of asthma were replicated at age 13 (OR: 0.22, 95% CI: 0.08; 0.56). At age 7, serum total IgE was reduced by 62.8% (CI 95%: -84.3%; -11.9%) in the vaccinated children. MMR vaccination was not significantly associated with allergic rhinoconjuctivitis symptoms, eczema, or SPT reactions at age 13.

Conclusions: MMR vaccination early in life may have a protective effect against allergy at least up to age 7 and against asthma through age 13 yrs.

Keywords: allergy; asthma; children; measles-mumps-rubella vaccination.

PubMed Disclaimer

References

    1. Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet. 1996; 347: 1792–6. - PubMed
    1. Paunio M, Heinonen OP, Virtanen M, Leinikki P, Patja A, Peltola H. Measles history and atopic diseases: a population-based cross-sectional study. JAMA : the journal of the American Medical Association. 2000; 283: 343–6. - PubMed
    1. Olesen AB, Juul S, Thestrup-Pedersen K. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Acta dermato-venereologica. 2003; 83: 445–50. - PubMed
    1. Nagel G, Weinmayr G, Flohr C, Kleiner A, Strachan DP, Group IPTS. Association of pertussis and measles infections and immunizations with asthma and allergic sensitization in ISAAC Phase Two. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2012; 23: 737–46. - PubMed
    1. Roost HP, Gassner M, Grize L, et al. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2004; 15: 401–7. - PubMed

Publication types

Substances